NIIMBL (The National Institute for Innovation in Manufacturing Biopharmaceuticals)

NIIMBL’s Viral Vector Program has awarded funding to Michigan Technological University to evaluate methods for detecting adeno-associated virus (AAV) aggregation in gene therapy manufacturing. The project will help the biopharmaceutical industry identify a reliable analytical method to support safe, cost-effective gene therapy production.

The...

NIIMBL is pleased to announce that six organizations have been selected to host the inaugural NIIMBL eXperience for Educators this summer. Each will offer a one- or two-day program introducing K-12 educators to the biopharmaceutical industry. The goal is to strengthen the industry’s talent pipelines by providing educators with knowledge, tools...

Following our milestone ten-year anniversary, 2025 was a year of continued innovation, engagement, and improvement experienced by the advanced manufacturing network and beyond.

Notable highlights from 2025 include:

In an effort to equip job seekers, employers, and trainers with the...